source:[1] Esusu's $1.2b valuation, Steelhead's $84m, and Apollo's golf IPO - Axios (https://amp.axios.com/pro-rata-premium-first- ...)[2] EpilepsyGTx Raises $33 Million Series A to Develop Single Dose Gene Therapy for Focal Refractory Epilepsy - BioSpace (https://www.biospace.com/press-releases/epile ...)[3] K2, Pryzm, South 8 and VATN detail their newest capital rounds - Washington Technology (https://www.washingtontechnology.com/companie ...)